Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPI-SEPSIS: Esomeprazole in Sepsis
NCT03452865Phase 3Completed
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Jan 2020
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in sepsis and septic shock comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Sequential Organ Failure Assessment Score Reduction. Started Jan 2020; status: completed.
02
Drugs
esomeprazole
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT03452865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03452865.